4//SEC Filing
Frieberg Jacob B. 4
Accession 0000891839-21-000234
CIK 0001205922other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:31 PM ET
Size
31.0 KB
Accession
0000891839-21-000234
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Frieberg Jacob B.
Director
Transactions
- Conversion
Option (Right to Acquire)
2021-06-25−44,200→ 0 total→ Common Stock (4,420 underlying) - Conversion
Option (Right to Acquire)
2021-06-25−75,000→ 0 total(indirect: By Gee Eff Services Limited)→ Common Stock (4,121 underlying) - Conversion
Common Stock
2021-06-25+4,420→ 57,286 total - Conversion
Common Stock
2021-06-25+4,121→ 4,121 total(indirect: By Gee Eff Services Limited)
Holdings
- 6,396
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying) - 6,545
Stock Option (Right to Buy)
Exercise: $2.07Exp: 2030-12-29→ Common Stock (6,545 underlying) - 15,679
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (15,679 underlying) - 3,756
Stock Option (Right to Buy)
Exercise: $3.61Exp: 2030-06-28→ Common Stock (3,756 underlying) - 7,626
Stock Option (Right to Buy)
Exercise: $1.78Exp: 2030-09-28→ Common Stock (7,626 underlying) - 2,501
Stock Option (Right to Buy)
Exercise: $5.26Exp: 2029-03-30→ Common Stock (2,501 underlying) - 7,718
Stock Option (Right to Buy)
Exercise: $7.78→ Common Stock (7,718 underlying) - 2,385
Stock Option (Right to Buy)
Exercise: $5.52Exp: 2029-06-29→ Common Stock (2,385 underlying) - 1,856
Stock Option (Right to Buy)
Exercise: $7.17Exp: 2029-09-27→ Common Stock (1,856 underlying) - 2,737
Stock Option (Right to Buy)
Exercise: $4.85Exp: 2029-12-28→ Common Stock (2,737 underlying) - 3,336
Stock Option (Right to Buy)
Exercise: $4.00Exp: 2030-03-29→ Common Stock (3,336 underlying) - 4,535
Stock Option (Right to Buy)
Exercise: $2.98Exp: 2031-03-31→ Common Stock (4,535 underlying) - 28,586
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
Footnotes (8)
- [F1]Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis.
- [F2]Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis.
- [F3]Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
- [F5]Exercisable in full as of the date of this report.
- [F6]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- [F7]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F8]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001748346
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:31 PM ET
- Size
- 31.0 KB